Paola Valsasina1, Maria Assunta Rocca1, Paolo Preziosa1, Mohammad Ahmad Abdullah Ali Aboulwafa1,2, Mark Andrew Horsfield3, Giancarlo Comi4, Andrea Falini5, and Massimo Filippi1
1Neuroimaging Research Unit, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy, 2Clinical Neurology Department, Faculty of Medicine, Al-Azhar University, Cairo, Egypt, 3Xinapse System Ltd, West Bergholt, Essex, United Kingdom, 4Department of Neurology, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy, 5Department of Neuroradiology, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy
Synopsis
In this study,
we performed a comprehensive assessment of cervical cord lesions in 133
patients with multiple sclerosis (MS) on 3D T1-weighted scans at 3.0 T. Lesion
occurrence, regional distribution, influence on cord atrophy and disability were
evaluated. T1 lesions were detected in a large proportion (85%) of MS patients,
with a higher frequency of cord lesions in the progressive than in the relapsing
forms of the disease. There was only a modest correlation between cord T1
lesions and atrophy. Both cord T1 lesions and atrophy were significant and
independent contributors to patient disability. Background and purpose
Multiple sclerosis (MS) is characterized by severe
involvement of the spinal cord. At 1.5 T, spinal cord MS lesions
have been described as rarely T1 hypointense [1], but the recent introduction
of high-field scanners and optimized sequences improved the ability to
detect T1 hypointensites in the upper cord [2,3].
While
preliminary studies at 3.0 T suggested that both upper cord lesion load and
cord atrophy contributed to disability [3], a full characterization of spinal
cord lesions on high-resolution T1-weighted scans along the entire cervical
cord segment is still missing. Moreover, the possible influence of T1 hypointensities
on cord atrophy estimation, cord tissue loss and disability has never been
explored.
Against this background, aims of our study were: 1) to characterize
the spatial distribution of cervical cord T1 lesions in a relatively large
cohort of MS patients; 2) to assess whether there was any influence of cord T1 lesions
on active surface (AS) [4] cord outline estimates; and 3) to analyze the
association between cord T1 lesions, atrophy and disability.
Methods
Sagittal 3D T1-weighted scans of the cervical cord were
acquired at 3.0 T from 133 patients with MS (63 relapsing remitting [RR], 30
secondary progressive [SP], 20 primary progressive [PP] and 20 benign [B] MS) and
47 controls.
T1-hypointense lesions were identified
by an experienced neurologist on the sagittal 3D T1 images. Lesions were
counted and binary lesion masks were produced. Then, the AS method was applied to
calculate cross-sectional area (CSA) between C1 and C7. The quality of cord outline
estimates was carefully reviewed. Unfolded cervical cord images were created by
reformatting the input images perpendicular to the estimated cord centre line. Straightened
images were coregistered to the average cord image of healthy controls, serving
as a cervical cord template [5]. The same transformation was applied to the cervical
cord masks and T1 lesion masks.
Between-group
comparisons of T1 lesions and cord atrophy were performed with ANOVA models
adjusted for age, using SPSS and SPM12 (global and regional analysis,
respectively). Multiple regression models were used to assess correlations
between T1 cord lesion number and extent, cord atrophy and patient clinical
disability.
Results
T1 hypointense lesions were detected in
114 (85%) of MS patients (53 RRMS, 28 SPMS, 16 PPMS and 17 BMS). The median
number of T1 lesions was 3 (range=0-11 lesions) and the average cord T1 lesion
volume was 0.3 ml (SD=0.3 ml). T1 lesion number and volume were not
significantly different between phenotypes (p=0.08 and 0.4, respectively). The
average T1 lesion probability maps in MS patients (as a whole) and in the
different phenotypes are shown in Figure 1. T1 lesions were more frequently
occurring in SPMS vs RRMS, and in
PPMS vs RRMS and SPMS patients,
especially in anterior and lateral upper cord segments (Figure 1).
Cord outlines were correctly estimated
by the AS method both in patients without and with T1 lesions (Figure 2). Significant
cord tissue loss was found in MS patients vs
controls, and 1) in RRMS and PPMS vs
controls (p<0.001); 2) in RRMS vs
BMS (p=0.01); and 3) in SPMS vs RRMS
patients (p=0.002). Cord atrophy did not differ between PPMS and SPMS patients
(Figure 3).
Whole-cord CSA was not correlated with cord
T1 lesion number/volume (p=0.8 and 0.3, respectively). The regional
distribution of cord atrophy was modestly correlated with T1 lesion number/volume
(Figure 4). Conversely, there was a strong correlation between cord atrophy and
disability, both at a global (r=-0.51, p<0.001) and regional analysis (Figure
4). The association between cord T1 lesions and EDSS was also significant, both
at a global (r=0.27, p=0.002) and regional level (Figure 4).
Conclusions
T1 hypointense cervical
cord lesions were detected in a large proportion (85%) of MS patients, with a
slightly higher frequency in the progressive than in the relapsing forms of the
disease. This widespread presence of T1 lesions did not influence cord area
estimates produced by the AS method, which were reliable in all study subjects.
This might be explained by the continuity constraints imposed by the AS method
on cord surface smoothness along the cord axis direction, and by the good
contrast between cord tissue and surrounding CSF [1]. The association between
cord T1 lesions and cord atrophy was modest. However, both cord T1 lesions and
atrophy were significant and independent contributors to patient physical
disability.
Acknowledgements
This study has been partially supported by a grant from
Fondazione Italiana Sclerosi multipla (FISM 2014/PMS/6).References
[1] Lycklama G., et
al. Lancet Neurol 2003; 2: 555-62.
[2] Nair G., et
al., Amer J Neuroradiol 2013; 34: 2215-22.
[3] Kearney H., et al.
Neurology 2015; 84: 367-73.
[4] Horsfield
M.A., et al. Neuroimage 2010;50:446-455.
[5] Valsasina
P., et al. Amer J Neuroradiol 2012; 33: 2195-200.